158090-53-0

Upstream product

• 158090-52-9 3-(benzhydryl-ethyl-sulfamoyl)-4-(3,5-di-tert-butyl-4-methoxymethoxyphenyl)-4-oxo-butyric acid tert-butyl ester 
• 75-09-2 dichloromethane 
• 158090-51-8 (3,5-di-tert-butyl-4-methoxymethoxybenzoyl)-N-ethyl-N-diphenylmethylmethanesulfonamide 
• 5292-43-3 bromoacetic acid tert-butyl ester 

Downstream Products

• 158090-54-1 4-(3,5-di-tert-butyl-4-methoxymethoxyphenyl)-3-ethyl-sulfamoyl-4-hydroxy-butyric acid tert-butyl ester 
• 158090-56-3 (E)-4-(3,5-di-tert-butyl-4-hydroxyphenyl)-3-ethylsulfamoyl-3-butenoic acid 
• 158090-57-4 (E)-5-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2-ethyl-1,2-isothiazolidine-3-one 1,1-dioxide 

Relevant academic research and scientific papers

Synthesis and activities of oxidative metabolites of the anti-arthritic drug candidate S-2474

We have synthesized and characterized some oxidative metabolites of S-2474. In this study, we discovered a novel skeleton, the 2,3-dihydrobenzofuran derivative, which inhibited PGE2 production at a very low concentration and was effective in th

Benzylidene derivatives

Benzylidene derivatives having anti-inflammatory activities, are shown by the following formula I: STR1 wherein A is -CH2 - or -CH2 CH2 -; B is a bond or -CH2 -, -CHOH-, -CO-, -O-, or A and B may taken together